Effects of acupuncture on Alzheimer's disease: the mechanistic study

An-Lan Zhao, Xiao-Xu Zhang, Jia-Xin Yuan, Hong-Yue Niu
{"title":"Effects of acupuncture on Alzheimer's disease: the mechanistic study","authors":"An-Lan Zhao, Xiao-Xu Zhang, Jia-Xin Yuan, Hong-Yue Niu","doi":"10.53388/psmr2023014","DOIUrl":null,"url":null,"abstract":"Alzheimer’s disease (AD) is a degenerative disease of the central nervous system characterized by memory loss and cognitive impairment, often accompanied by emotional apathy, agitation, depression, delusions aggression, and other psychological symptoms [1–3]. Psychological symptoms such as apathy, agitation, and depression tend to increase with the duration and severity of AD, seriously affecting the prognosis of patients, and also bringing a heavy burden to society and families [4]. The pathology of AD is characterized by nerve cell dysfunctions and loss of neurons in the central nervous system, ultimately leading to mental changes [5]. However, the etiology of AD is still unclear, among which the recognized mainstream theories include the cholinergic hypothesis, Amyloid β-protein (Aβ) cascade hypothesis, and inflammatory response, etc. Current AD pharmacotherapy relies on cognitive enhancement therapy, and only five AD medications have been approved by the Food and Drug Administration [5], including cholinesterase inhibitors [6] (including tacrine, donepezil, rivastigmine, and galantamine) and Nmethyl-D-aspartate receptor antagonists (memantine) [7]. These drugs have toxic side effects and only temporarily relieve AD symptoms, but can not stop or slow the progression of AD, rather than meeting the clinical need. In addition, the efficacy and safety of drugs targeting Aβ in ameliorating cognitive decline in patients have been greatly questioned. Therefore the search for effective AD treatments remains urgent and challenging. Acupuncture is a non-pharmacologic therapy of traditional Chinese medicine, dating back at least 2,000 years. Its attention and acceptance are growing worldwide, showing promising therapeutic effects and good safety. And we are pleased to see that the number and quality of randomized controlled trials of acupuncture for AD have increased in recent years to scientifically demonstrate the efficacy and safety of acupuncture for AD [8].","PeriodicalId":497938,"journal":{"name":"Psychosomatic medicine research","volume":"55 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychosomatic medicine research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.53388/psmr2023014","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Alzheimer’s disease (AD) is a degenerative disease of the central nervous system characterized by memory loss and cognitive impairment, often accompanied by emotional apathy, agitation, depression, delusions aggression, and other psychological symptoms [1–3]. Psychological symptoms such as apathy, agitation, and depression tend to increase with the duration and severity of AD, seriously affecting the prognosis of patients, and also bringing a heavy burden to society and families [4]. The pathology of AD is characterized by nerve cell dysfunctions and loss of neurons in the central nervous system, ultimately leading to mental changes [5]. However, the etiology of AD is still unclear, among which the recognized mainstream theories include the cholinergic hypothesis, Amyloid β-protein (Aβ) cascade hypothesis, and inflammatory response, etc. Current AD pharmacotherapy relies on cognitive enhancement therapy, and only five AD medications have been approved by the Food and Drug Administration [5], including cholinesterase inhibitors [6] (including tacrine, donepezil, rivastigmine, and galantamine) and Nmethyl-D-aspartate receptor antagonists (memantine) [7]. These drugs have toxic side effects and only temporarily relieve AD symptoms, but can not stop or slow the progression of AD, rather than meeting the clinical need. In addition, the efficacy and safety of drugs targeting Aβ in ameliorating cognitive decline in patients have been greatly questioned. Therefore the search for effective AD treatments remains urgent and challenging. Acupuncture is a non-pharmacologic therapy of traditional Chinese medicine, dating back at least 2,000 years. Its attention and acceptance are growing worldwide, showing promising therapeutic effects and good safety. And we are pleased to see that the number and quality of randomized controlled trials of acupuncture for AD have increased in recent years to scientifically demonstrate the efficacy and safety of acupuncture for AD [8].
针刺治疗阿尔茨海默病的机制研究
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信